3-(PHENYLAMINO)ALANINE, A NOVEL ANILINE-DERIVED AMINO-ACID ASSOCIATED WITH THE EOSINOPHILIA-MYALGIA-SYNDROME - A LINK TO THE TOXIC OIL SYNDROME

被引:61
作者
MAYENO, AN
BELONGIA, EA
LIN, F
LUNDY, SK
GLEICH, GJ
机构
[1] MAYO CLIN & MAYO FDN, DEPT IMMUNOL, ROCHESTER, MN 55905 USA
[2] MAYO CLIN & MAYO FDN, ALLERG DIS RES LAB, ROCHESTER, MN 55905 USA
[3] MAYO CLIN & MAYO FDN, RHEUMATOL RES UNIT, ROCHESTER, MN 55905 USA
[4] MINNESOTA DEPT HLTH, ALLERG DIS RES LAB, MINNEAPOLIS, MN USA
[5] MINNESOTA DEPT HLTH, ACUTE DIS EPIDEMIOL SECT, MINNEAPOLIS, MN USA
关键词
D O I
10.1016/S0025-6196(12)61142-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The eosinophilia-myalgia syndrome (EMS) is an inflammatory disease that occurred in epidemic proportions in the United States during 1989. Cases of EMS were also reported in Europe and elsewhere. Clinically, EMS resembles the Spanish toxic oil syndrome. EMS has been associated with ingestion of manufactured L-tryptophan and, more specifically, with lots of tryptophan that contained the trace contaminant 1,1'-ethylidenebis(tryptophan) (EBT). Another trace contaminant ("peak UV-5") has been reported, but the strength of its association with EMS has not been demonstrated. Herein we report independently that peak UV-5 is 3-(phenylamino)alanine (PAA). Patients with EMS ingested significantly greater amounts of both PAA and EBT than did control tryptophan users. PAA is chemically similar to 3-phenylamino-1,2-propanediol, an aniline derivative isolated from samples of oil that were consumed by persons in whom the toxic oil syndrome developed. The discovery of an aniline-derived contaminant in tryptophan raises the possibility that EMS and toxic oil syndrome may have a common etiologic trigger.
引用
收藏
页码:1134 / 1139
页数:6
相关论文
共 31 条
  • [1] AN INVESTIGATION OF THE CAUSE OF THE EOSINOPHILIA-MYALGIA SYNDROME ASSOCIATED WITH TRYPTOPHAN USE
    BELONGIA, EA
    HEDBERG, CW
    GLEICH, GJ
    WHITE, KE
    MAYENO, AN
    LOEGERING, DA
    DUNNETTE, SL
    PIRIE, PL
    MACDONALD, KL
    OSTERHOLM, MT
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (06) : 357 - 365
  • [2] L-TRYPTOPHAN IMPLICATED IN HUMAN EOSINOPHILIA-MYALGIA-SYNDROME CAUSES FASCIITIS AND PERIMYOSITIS IN THE LEWIS RAT
    CROFFORD, LJ
    RADER, JI
    DALAKAS, MC
    HILL, RH
    PAGE, SW
    NEEDHAM, LL
    BRADY, LS
    HEYES, MP
    WILDER, RL
    GOLD, PW
    ILLA, I
    SMITH, C
    STERNBERG, EM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (05) : 1757 - 1763
  • [3] DUNCAN MW, 1991, ADV NEUROL, V56, P301
  • [4] DURAN RM, 1986, GRASAS ACEITES, V37, P207
  • [5] A CASE OF THE EOSINOPHILIA-MYALGIA SYNDROME ASSOCIATED WITH USE OF AN L-TRYPTOPHAN PRODUCT
    FLANNERY, MT
    WALLACH, PM
    ESPINOZA, LR
    DOHRENWEND, MP
    MOSCINSKI, LC
    [J]. ANNALS OF INTERNAL MEDICINE, 1990, 112 (04) : 300 - 301
  • [6] GODA Y, 1992, CHEM PHARM BULL, V40, P2236
  • [7] Greenstein J. P., 1961, CHEM AMINO ACIDS
  • [8] L-TRYPTOPHAN AND THE EOSINOPHILIA-MYALGIA-SYNDROME - PATHOLOGICAL FINDINGS IN 8 PATIENTS
    HERRICK, MK
    CHANG, Y
    HOROUPIAN, DS
    LOMBARD, CM
    ADORNATO, BT
    [J]. HUMAN PATHOLOGY, 1991, 22 (01) : 12 - 21
  • [9] ASSOCIATION OF THE EOSINOPHILIA MYALGIA SYNDROME WITH THE INGESTION OF TRYPTOPHAN
    HERTZMAN, PA
    BLEVINS, WL
    MAYER, J
    GREENFIELD, B
    TING, M
    GLEICH, GJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (13) : 869 - 873
  • [10] HERTZMAN PA, 1991, J RHEUMATOL, V18, P867